Michael Reusch

2.4k total citations
79 papers, 1.6k citations indexed

About

Michael Reusch is a scholar working on Dermatology, Oncology and Hematology. According to data from OpenAlex, Michael Reusch has authored 79 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Dermatology, 24 papers in Oncology and 22 papers in Hematology. Recurrent topics in Michael Reusch's work include Erythropoietin and Anemia Treatment (22 papers), Cutaneous Melanoma Detection and Management (22 papers) and Dermatology and Skin Diseases (14 papers). Michael Reusch is often cited by papers focused on Erythropoietin and Anemia Treatment (22 papers), Cutaneous Melanoma Detection and Management (22 papers) and Dermatology and Skin Diseases (14 papers). Michael Reusch collaborates with scholars based in Germany, United States and Netherlands. Michael Reusch's co-authors include Tadao Akizawa, Matthias Augustin, Yusuke Yamaguchi, Manabu Iwasaki, Jonathan Barratt, Udaya Valluri, Marc Alexander Radtke, Ines Schäfer, Michael Schömig and Stephan Jeff Rustenbach and has published in prestigious journals such as Scientific Reports, Journal of the American Society of Nephrology and Journal of Investigative Dermatology.

In The Last Decade

Michael Reusch

77 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Reusch Germany 21 707 478 314 280 277 79 1.6k
Grace S. Park United States 19 221 0.3× 114 0.2× 82 0.3× 409 1.5× 119 0.4× 31 1.4k
Tim Littlewood United Kingdom 23 1.3k 1.8× 25 0.1× 36 0.1× 134 0.5× 345 1.2× 62 1.8k
Quentin A. Hill United Kingdom 21 1.2k 1.7× 24 0.1× 137 0.4× 353 1.3× 207 0.7× 60 1.8k
Alessandro Corso Italy 25 2.4k 3.4× 42 0.1× 51 0.2× 217 0.8× 1.6k 5.8× 114 3.3k
R. Fleischmann United States 11 300 0.4× 136 0.3× 116 0.4× 324 1.2× 205 0.7× 38 1.5k
Massimo Iacobelli United States 19 1.1k 1.5× 11 0.0× 176 0.6× 422 1.5× 272 1.0× 54 1.9k
Arijit Ganguli United States 22 191 0.3× 227 0.5× 65 0.2× 360 1.3× 126 0.5× 90 1.4k
Luisa Ponchio Italy 18 1000 1.4× 21 0.0× 15 0.0× 274 1.0× 578 2.1× 47 1.8k
Kurt W. Tauer United States 15 373 0.5× 67 0.1× 30 0.1× 745 2.7× 1.1k 3.8× 31 1.8k
Tracy Cardillo United States 9 252 0.4× 173 0.4× 100 0.3× 220 0.8× 200 0.7× 13 1.1k

Countries citing papers authored by Michael Reusch

Since Specialization
Citations

This map shows the geographic impact of Michael Reusch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Reusch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Reusch more than expected).

Fields of papers citing papers by Michael Reusch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Reusch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Reusch. The network helps show where Michael Reusch may publish in the future.

Co-authorship network of co-authors of Michael Reusch

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Reusch. A scholar is included among the top collaborators of Michael Reusch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Reusch. Michael Reusch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zarbock, Alexander, Tobias E. Larsson, Nicolas Noiseux, et al.. (2024). Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial. EClinicalMedicine. 76. 102830–102830. 3 indexed citations
2.
Ganz, Tomas, Francesco Locatelli, Mustafa Arıcı, Tadao Akizawa, & Michael Reusch. (2023). Iron Parameters in Patients Treated with Roxadustat for Anemia of Chronic Kidney Disease. Journal of Clinical Medicine. 12(13). 4217–4217. 14 indexed citations
3.
4.
Esposito, Ciro, Jonathan Barratt, Frank Dellanna, et al.. (2022). Iron Parameters in Patients Treated With Roxadustat for Anemia Associated With Chronic Kidney Disease: Post Hoc Analysis of the Non-Dialysis-Dependent or Incident Dialysis Population From Four Phase 3 Studies. SPIRE - Sciences Po Institutional REpository. 1 indexed citations
5.
Barratt, Jonathan, et al.. (2020). Roxadustat for the Treatment of Anemia in CKD Patients Not on Dialysis (NDD): A Phase 3, Randomized, Open-Label, Active-Controlled Study. Journal of the American Society of Nephrology. 31(10S). 1–1. 2 indexed citations
6.
7.
Topp, Jesco, et al.. (2019). Measuring Patient Needs and Benefits in Dermatology using the Patient Benefit Index 2.0: A Validation Study. Acta Dermato Venereologica. 99(2). 211–217. 6 indexed citations
8.
9.
Schäfer, Ingo, et al.. (2017). Assoziation von Krankenversicherung und soziodemografischen Faktoren mit der Versorgung maligner Melanome. Aktuelle Dermatologie. 43(3). 97–104. 1 indexed citations
10.
Eissing, L., Ingo Schäfer, Klaus Strömer, et al.. (2017). Die Wahrnehmung des gesetzlichen Hautkrebsscreenings in der Allgemeinbevölkerung. Der Hautarzt. 68(5). 371–376. 23 indexed citations
11.
Augustin, Jobst, I. Schäfer, Michael Reusch, & Matthias Augustin. (2016). Risikomerkmale und Überlebensrate des malignen Melanoms in Deutschland und den Niederlanden. Der Hautarzt. 67(12). 996–1002. 1 indexed citations
12.
Augustin, Matthias, L. Eissing, Anna Langenbruch, et al.. (2016). The German National Program on Psoriasis Health Care 2005–2015: results and experiences. Archives of Dermatological Research. 308(6). 389–400. 48 indexed citations
13.
Garbe, Claus, Thomas Eigentler, Jürgen Bauer, et al.. (2016). Mitoserate beim primären Melanom: Interobserver‐ und Intraobserver‐Reproduzierbarkeit am HE‐Schnitt und in der Immunhistologie. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 14(9). 910–916. 15 indexed citations
14.
Reusch, Michael & Enno Christophers. (2015). Psoriasis: A Continuing Challenge for Phototherapy. Current problems in dermatology. 15. 219–231.
15.
Boecker, Werner, Michael Reusch, Horst Buerger, et al.. (2012). Origin and differentiation of breast nipple syringoma. Scientific Reports. 2(1). 226–226. 7 indexed citations
16.
Augustin, Matthias, Rudolf Stadler, Michael Reusch, et al.. (2011). Skin cancer screening in Germany – perception by the public. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 10(1). 42–49. 39 indexed citations
17.
Augustin, Matthias, Christine Blome, Stephan Jeff Rustenbach, Michael Reusch, & Marc Alexander Radtke. (2010). Routine skin cancer screening in Germany: First data on the impact on health care in dermatology. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 8(9). 674–680. 11 indexed citations
18.
Reusch, Michael, Jonathan Mansbridge, B J Nickoloff, & Vera B. Morhenn. (1991). Immunophenotyping of Skin Cells during Healing of Suction Blister Injury. Dermatology. 183(3). 179–183. 15 indexed citations
19.
Reusch, Michael, et al.. (1988). Leukotriene B4 enhances adherence of human polymorphonuclear leukocytes to dermal microvascular endothelial cells in vitro. Archives of Dermatological Research. 280(4). 194–197. 4 indexed citations
20.
Reusch, Michael, Marvin A. Karasek, & B J Nickoloff. (1988). Effect of neuropeptides present in skin on the proliferation of human peripheral blood mononuclear cells and T cells. Archives of Dermatological Research. 280(5). 279–281. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Grace S. Park Breakdown of academic impact, for papers by Tim Littlewood Breakdown of academic impact, for papers by Quentin A. Hill Breakdown of academic impact, for papers by Alessandro Corso Breakdown of academic impact, for papers by R. Fleischmann Breakdown of academic impact, for papers by Massimo Iacobelli Breakdown of academic impact, for papers by Arijit Ganguli Breakdown of academic impact, for papers by Luisa Ponchio Breakdown of academic impact, for papers by Kurt W. Tauer Breakdown of academic impact, for papers by Tracy Cardillo
Rankless by CCL
2026